UMIN ID: UMIN000032227
Registered date:15/04/2018
Clinical trial for Yamakagashi and Redback spider bites
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Yamakagashi and Redback spider bites |
Date of first enrollment | 2018/04/20 |
Target sample size | 2 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Yamakagashi and redback spider antivenom |
Outcome(s)
Primary Outcome | Survival rate |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Informend consent was not obtained Inappropriate for the study |
Related Information
Primary Sponsor | St.Luke International Hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | AMED |
Secondary ID(s) |
Contact
public contact | |
Name | Toru Hifumi |
Address | 9-1, Akashicho, Chuouku, Tokyo, 104-8560, Japan Japan 104-8560 |
Telephone | 03-3541-5151 |
hitoru@luke.ac.jp | |
Affiliation | St.Luke International Hospital Department of Emergency and Critical Care Medicine |
scientific contact | |
Name | Toru Hifumi |
Address | 9-1, Akashicho, Chuouku, Tokyo, 104-8560, Japan Japan |
Telephone | 03-3541-5151 |
hitoru@luke.ac.jp | |
Affiliation | St.Luke International Hospital Department of Emergency and Critical Care Medicine |